- Home
- RTO vs RVMD Comparison
RTO vs RVMD Comparison
Compare RTO & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RTO | RVMD |
|---|---|---|
| Founded | 1925 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | 809 |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 15.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | RTO | RVMD |
|---|---|---|
| Price | $29.80 | $77.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | N/A | ★ $77.47 |
| AVG Volume (30 Days) | 677.3K | ★ 2.5M |
| Earning Date | 01-21-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $7,581,860,530.00 | N/A |
| Revenue This Year | $48.64 | N/A |
| Revenue Next Year | $3.22 | $714.50 |
| P/E Ratio | $222.46 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.60 | $29.17 |
| 52 Week High | $30.16 | $81.49 |
Technical Indicators
Market Signals| Indicator | RTO | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.39 | 64.72 |
| Support Level | $28.45 | $74.20 |
| Resistance Level | $30.16 | $80.44 |
| Average True Range (ATR) | 0.39 | 2.70 |
| MACD | 0.14 | -0.93 |
| Stochastic Oscillator | 86.62 | 58.03 |
Price Performance
Historical ComparisonAbout RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.